Why on earth is Craig Biggio above steroid suspicion?

71 Comments

Here we have Bill Madden’s latest gem of a column, which contains enough strawmen to fill up Citi Field. In it, he promotes Jack Morris and Craig Biggio for the Hall of Fame, and while he doesn’t unequivocally state that they are the only two players he is voting for, the column certainly suggests it.

I’ve tackled Morris before and will again tomorrow, but let’s concentrate on Biggio for a moment. Biggio is being promoted by Madden and others as this year’s clean candidate, whereas his longtime Astros teammate, Jeff Bagwell, has had his candidacy tainted by steroids.

What I don’t get is why one if not the other?

The case against Bagwell is that he showed little power as a youngster, befriended noted steroids user Ken Caminti, got a lot stronger in the majors and then turned into one of the game’s best players.

And that differs from Biggio how? Biggio hit four homers in 555 at-bats at age 24, four homers in 546 at-bats at age 25 and six homers in 613 at-bats at age 26 before turning in the first of seven 20-homer campaigns at age 27.  His career high of 26 homers came at age 39.

Furthermore, Bagwell and Biggio were good friends who spent 15 years as teammates. I have my doubts that the training methods of one were a secret to the other. If Bagwell was on something, one would think there’s a more than slight chance that Biggio was on it, too.

So why does Biggio get trumped up as clean? Because he was a middle infielder? Because he hit 20 homers per year rather than 40? I’ll give you that Biggio wasn’t quite as stacked as Bagwell in his prime, but the guy had some muscles.

Personally, I’m very much in favor of putting Biggio into the Hall, just as I’m in favor of Bagwell’s candidacy. Part of Biggio’s power spike can be attributed to him leaving the Astrodome for Enron Field/Minute Maid Park. Towards the end of his career, once he realized he could no longer cover the entire plate, he made a conscious decision to become more of a pull hitter and take aim at the shallow left field porch at Enron.

Biggio was a favorite of mine, and I’d like to think he spent his entire career steroid-free. My point here isn’t to label Biggio a cheater. It’s simply to say that we don’t know, and that anyone that would go to lengths to promote him as the clean candidate is either naive or stupid.

Royals sign Drew Storen to minor league deal

Drew Storen
Getty Images
Leave a comment

The Royals are in agreement with right-handed reliever Drew Storen on a minor league deal, the team announced Friday. Per Jon Heyman of MLB Network, the deal is worth $1.25 million if the veteran righty breaks camp with the club this spring. Additional, albeit unspecified incentives will be included in the contract as well.

Storen, 31, is coming off of a protracted absence from any MLB duties. After inking a one-year deal with the Reds in 2017, he sustained a right elbow sprain toward the end of the year and underwent Tommy John surgery that October. He was effectively decommissioned for the club’s entire 2018 run and generated little interest around the league this winter, perhaps due in part to the uninspired 4.45 ERA, 3.8 BB/9, 7.9 SO/9, and career-low -0.2 fWAR he posted across 54 2/3 innings during his last healthy season.

While it’s not immediately clear what kind of performance the Royals can expect from Storen in spring training, they’re not exactly in a position to be choosy. Their bullpen ranked dead last among all MLB teams with a collective 5.04 ERA, 4.85 FIP, and -2.2 fWAR last year, and still appears to be in a state of flux as they approach Opening Day. Skipper Ned Yost told reporters Wednesday that he intends to eschew the traditional closer appointment in 2019 and will instead utilize a combination of right-handers Wily Peralta and Brad Boxberger, lefty Tim Hill, and various others as he tackles high-leverage situations in the future.